Skip to main content
GaldermaRevenue

Skincare company Galderma posts 25.5% sales leap, driven by US market.

What happened

Galderma Pharma S.A had revenue of $1.47B on Apr 23rd '26.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Skincare company Galderma posts 25.5% sales leap, driven by US market. Swiss skincare company Galderma said on Thursday that first-quarter sales jumped 25.5% in constant-currency terms to $1.47 billion and signalled it could manage the impact of US tariffs in 2026. The Zug-based group was buoyed by strong demand in the US, where sales surged 41.5% year on year in the January-March period. "Based on the strong start to the year, the guidance is increasingly being de-risked with confidence to navigate a volatile environment," Galderma said in a statement. The results lifted the company's shares, which were up more than 6% shortly before 0900 GMT. Galderma, which was listed on the Swiss stock exchange just over two years ago, said its exposure to US tariffs was expected to remain "manageable" this year. Chief executive Flemming Ornskov said sales of its injectable dermatitis treatment Nemluvio were very strong, with US demand for dermatological skincare products particularly robust on Amazon and other e-commerce platforms. Ornskov told Reuters that Galderma was gaining market share in the US, and was monitoring how companies handled potential refunds linked to tariffs struck down by the US Supreme Court. Any amounts owed would not materially change the group's 2026 financial outlook, he said. Galderma has so far managed to mitigate the impact of the conflict in the Middle...

Keep reading with a free account

The rest of this article, and every signal for Galderma, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Revenue

What this signalsRevenue results often set the next budget cycle.

Amount named
$1.5B
Takes effect
Apr 23, 2026
Amount as written
$1.47 billion

More revenue signals at other companies

The full record

From the Signal API record

Numbers

Amount named in the story
$1.5B

Details

Category
Has revenue

Extraction

Confidence
65%
Detected
Apr 23, 2026
signal_type
news
signal_subtype
has_revenue

Use this data

Get every revenue signal for Galderma and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Galderma this week?”

  2. Send it to your own tools

    The Signal API returns revenue signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/03272870-4ca7-4282-8e20-968ede05ec25 returns this record as JSON. POST /v1/companies/enrich returns every signal for galderma.com.

{
  "signal_id": "03272870-4ca7-4282-8e20-968ede05ec25",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-04-23T10:03:43+00:00",
  "company": {
    "name": "Galderma",
    "domain": "galderma.com"
  },
  "data": {
    "url": "https://us.fashionnetwork.com/news/Skincare-company-galderma-posts-25-5-sales-leap-driven-by-us-market,1826411.html",
    "title": "Skincare company Galderma posts 25.5% sales leap, driven by US market.",
    "amount": "$1.47 billion",
    "excerpt": "Skincare company Galderma posts 25.5% sales leap, driven by US market.\n\nSwiss skincare company Galderma said on Thursday that first-quarter sales jumped 25.5% in constant-currency terms to $1.47 billion and signalled it could manage the impact of US tariffs in 2026. The Zug-based group was buoyed by strong demand in the US, where sales surged 41.5% year on year in the January-March period.\n\n\"Based on the strong start to the year, the guidance is increasingly being de-risked with confidence to navigate a volatile environment,\" Galderma said in a statement. The results lifted the company's shares, which were up more than 6% shortly before 0900 GMT.\n\nGalderma, which was listed on the Swiss stock exchange just over two years ago, said its exposure to US tariffs was expected to remain \"manageable\" this year. Chief executive Flemming Ornskov said sales of its injectable dermatitis treatment Nemluvio were very strong, with US demand for dermatological skincare products particularly robust on Amazon and other e-commerce platforms.\n\nOrnskov told Reuters that Galderma was gaining market share in the US, and was monitoring how companies handled potential refunds linked to tariffs struck down by the US Supreme Court.\nAny amounts owed would not materially change the group's 2026 financial outlook, he said.\n\nGalderma has so far managed to mitigate the impact of the conflict in the Middle...",
    "summary": "Galderma Pharma S.A had revenue of $1.47B on Apr 23rd '26.",
    "category": "has_revenue",
    "found_at": "2026-04-23T10:03:43Z",
    "planning": false,
    "image_url": "https://media.fashionnetwork.com/cdn-cgi/image/fit=cover,width=600,height=600,format=auto/m/0b7a/4f4a/747a/54be/657b/a599/35d5/032a/6fce/8dce/8dce.jpg",
    "confidence": 0.6469,
    "published_at": "2026-04-23T10:03:43Z",
    "effective_date": "2026-04-23",
    "article_sentence": "Swiss skincare company Galderma said on Thursday that first-quarter sales jumped 25.5% in constant-currency terms to $1.47 billion and signalled it could manage the impact of US tariffs in 2026.",
    "amount_normalized": 1470000000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.